electrospray ionization mass spectrometry

A Mayo Clinic research group that previously evaluated Abbott's PCR-electrospray ionization mass spectrometry platform to broadly identify fungal infections has now published research demonstrating the system's ability to identify Mycobacterium species and M.

Researchers from the Mayo Clinic have demonstrated that Abbott's Plex-ID broad fungal assay is as good or in some cases better than culture-based methods for identifying fungal infections to the species level directly from respiratory specimens without prior knowledge of the offending orga

Scientists from Abbott and collaborating academic institutions have recently published a pair of studies demonstrating the ability of Abbott's Plex-ID platform to detect and identify in human samples a wide array of clinically relevant infectious organisms not picked up using mor

NEWPORT BEACH, Calif. – Scientists at Abbott subsidiary Ibis Biosciences have developed an assay to detect and genotype Borrelia burgdorferi, the bacterium responsible for causing Lyme disease in humans, using Abbott's Plex-ID microbial identification system.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – PerkinElmer is suing Agilent for infringement of two patents covering mass spectrometry technology.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Waters and Protea Biosciences today announced a co-marketing deal to offer customers Waters' SYNAPT G2 & G2-S HDMS systems with Protea's LAESI DP-1000.

Abbott said today that it has entered into an agreement with the University of North Texas Health Science Center to evaluate the company's Plex-ID instrument for use in analyzing human remains to support missing persons and human trafficking investigations.

The company will use GSG Mess-und Analysnegerate for marketing and distribution in Germany, Austria, and Switzerland.

Abbott's Plex-ID system, which combines PCR and mass spec analysis, will help authorities at state public health labs identify and characterize microorganisms in surveillance activities for infectious diseases, food safety analysis, and biodefense readiness.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.